Diagnosis requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of treatment regimens for insulin resistance require individualized development, typically including drug therapy, rehabilitation interventions, regular follow-up visits, and more.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions, adapting timely to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of glucocortical hormone resistance.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.